Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Context Therapeutics Q2 EPS $(0.25)

Context Therapeutics Q2 EPS $(0.25)

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.

August 11, 2022

1 minute read

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.

Recap Of Tuesday’s Biotech Catalysts – End Of the Day Summary

August 16, 5:54 PM

The U.S. Food and Drug Administration (FDA) has approved Amphastar’s (NASDAQ:AMPH) New Drug Application (ND”) for Epinephrine injection…

Yesterday, 1:24 PM

Atreca, Inc. (NASDAQ: BCEL) shares are volatile on Thursday and currently trading up by 48%. Here's a look at what's going on:

August 4, 6:31 AM

Piper Sandler analyst Matt Farrell maintains Match Group (NASDAQ:MTCH) with a Overweight and lowers the price target from $125 to $80.

December 1, 4:58 PM

-Reuters